Drawing for CC TRIALSUITE

USPTO serial 90550283

CC TRIALSUITE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BUSH, KAREN K
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CC TRIALSUITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William F Lang IV

William F Lang IV LANG PATENT LAW LLC309 COLLEGE AVE., SUITE BBEAVER, PA 15009UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
036(Based on Intent to Use) Payment processing services in the field of clinical trial patient reimbursement paymentsACTIVE—
038(Based on Intent to Use) Text messaging services; Video conferencing servicesACTIVE—
042(Based on Use in Commerce) Software as a service (SAAS) services featuring software for Clinical trial management, financial management for clinical trials, recruitment of patients for clinical trials, management of patients during clinical trials, providing centralized oversight for multiple clinical trial sites and studies, and reporting for clinical trials; permitting patients to consent electronically to participate in clinical trials and for assessing patient understanding of the nature of their consent; document management for regulatory compliance during clinical trials; remote monitoring of clinical trial patients, realtime data collection from clinical trial patients, secure sharing of data collected from clinical trial patients; Providing on-line non-downloadable software for Clinical trial management, financial management for clinical trials, recruitment of patients for clinical trials, management of patients during clinical trials, providing centralized oversight for multiple clinical trial sites and studies, and reporting for clinical trials; permitting patients to consent electronically to participate in clinical trials and for assessing patient understanding of the nature of their consent; document management for regulatory compliance during clinical trials; remote monitoring of clinical trial patients, realtime data collection from clinical trial patients, secure sharing of data collected from clinical trial patientsACTIVEFeb 24, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 6, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 6, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 25, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 2, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 5, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 10, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 10, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 20, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 5, 2022PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 5, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 17, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 17, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 16, 2022ALIEASSIGNED TO LIE—
Mar 14, 2022ALIEASSIGNED TO LIE—
Mar 11, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 23, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2021DOCKASSIGNED TO EXAMINER—
May 28, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 26, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Mar 2, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance